Cargando…

Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation

BACKGROUND: Early life stress (ELS) is associated with the development of schizophrenia later in life. The hippocampus develops significantly during childhood and is extremely reactive to stress. In rodent models, ELS can induce neuroinflammation, hippocampal neuronal loss, and schizophrenia-like be...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Keke, Wang, Huiling, Zhang, Yuejin, Xie, Xinhui, Huang, Huan, Chen, Cheng, Xu, Shilin, Xu, Rui, Shu, Chang, Liu, Zhongchun, Zhou, Yuan, Reynolds, Gavin P., Wang, Gaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494869/
https://www.ncbi.nlm.nih.gov/pubmed/36131290
http://dx.doi.org/10.1186/s12974-022-02591-y
_version_ 1784793885343481856
author Hao, Keke
Wang, Huiling
Zhang, Yuejin
Xie, Xinhui
Huang, Huan
Chen, Cheng
Xu, Shilin
Xu, Rui
Shu, Chang
Liu, Zhongchun
Zhou, Yuan
Reynolds, Gavin P.
Wang, Gaohua
author_facet Hao, Keke
Wang, Huiling
Zhang, Yuejin
Xie, Xinhui
Huang, Huan
Chen, Cheng
Xu, Shilin
Xu, Rui
Shu, Chang
Liu, Zhongchun
Zhou, Yuan
Reynolds, Gavin P.
Wang, Gaohua
author_sort Hao, Keke
collection PubMed
description BACKGROUND: Early life stress (ELS) is associated with the development of schizophrenia later in life. The hippocampus develops significantly during childhood and is extremely reactive to stress. In rodent models, ELS can induce neuroinflammation, hippocampal neuronal loss, and schizophrenia-like behavior. While nicotinamide (NAM) can inhibit microglial inflammation, it is unknown whether NAM treatment during adolescence reduces hippocampal neuronal loss and abnormal behaviors induced by ELS. METHODS: Twenty-four hours of maternal separation (MS) of Wistar rat pups on post-natal day (PND)9 was used as an ELS. On PND35, animals received a single intraperitoneal injection of BrdU to label dividing neurons and were given NAM from PND35 to PND65. Behavioral testing was performed. Western blotting and immunofluorescence staining were used to detect nicotinamide adenine dinucleotide (NAD(+))/Sirtuin3 (Sirt3)/superoxide dismutase 2 (SOD2) pathway-related proteins. RESULTS: Compared with controls, only MS animals in the adult stage (PND56–65) but not the adolescent stage (PND31–40) exhibited pre-pulse inhibition deficits and cognitive impairments mimicking schizophrenia symptoms. MS decreased the survival and activity of puberty-born neurons and hippocampal NAD(+) and Sirt3 expression in adulthood. These observations were related to an increase in acetylated SOD2, microglial activation, and significant increases in pro-inflammatory IL-1β, TNF-α, and IL-6 expression. All the effects of MS at PND9 were reversed by administering NAM in adolescence (PND35–65). CONCLUSIONS: MS may lead to schizophrenia-like phenotypes and persistent hippocampal abnormalities. NAM may be a safe and effective treatment in adolescence to restore normal hippocampal function and prevent or ameliorate schizophrenia-like behavior. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-022-02591-y.
format Online
Article
Text
id pubmed-9494869
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94948692022-09-23 Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation Hao, Keke Wang, Huiling Zhang, Yuejin Xie, Xinhui Huang, Huan Chen, Cheng Xu, Shilin Xu, Rui Shu, Chang Liu, Zhongchun Zhou, Yuan Reynolds, Gavin P. Wang, Gaohua J Neuroinflammation Research BACKGROUND: Early life stress (ELS) is associated with the development of schizophrenia later in life. The hippocampus develops significantly during childhood and is extremely reactive to stress. In rodent models, ELS can induce neuroinflammation, hippocampal neuronal loss, and schizophrenia-like behavior. While nicotinamide (NAM) can inhibit microglial inflammation, it is unknown whether NAM treatment during adolescence reduces hippocampal neuronal loss and abnormal behaviors induced by ELS. METHODS: Twenty-four hours of maternal separation (MS) of Wistar rat pups on post-natal day (PND)9 was used as an ELS. On PND35, animals received a single intraperitoneal injection of BrdU to label dividing neurons and were given NAM from PND35 to PND65. Behavioral testing was performed. Western blotting and immunofluorescence staining were used to detect nicotinamide adenine dinucleotide (NAD(+))/Sirtuin3 (Sirt3)/superoxide dismutase 2 (SOD2) pathway-related proteins. RESULTS: Compared with controls, only MS animals in the adult stage (PND56–65) but not the adolescent stage (PND31–40) exhibited pre-pulse inhibition deficits and cognitive impairments mimicking schizophrenia symptoms. MS decreased the survival and activity of puberty-born neurons and hippocampal NAD(+) and Sirt3 expression in adulthood. These observations were related to an increase in acetylated SOD2, microglial activation, and significant increases in pro-inflammatory IL-1β, TNF-α, and IL-6 expression. All the effects of MS at PND9 were reversed by administering NAM in adolescence (PND35–65). CONCLUSIONS: MS may lead to schizophrenia-like phenotypes and persistent hippocampal abnormalities. NAM may be a safe and effective treatment in adolescence to restore normal hippocampal function and prevent or ameliorate schizophrenia-like behavior. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-022-02591-y. BioMed Central 2022-09-21 /pmc/articles/PMC9494869/ /pubmed/36131290 http://dx.doi.org/10.1186/s12974-022-02591-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hao, Keke
Wang, Huiling
Zhang, Yuejin
Xie, Xinhui
Huang, Huan
Chen, Cheng
Xu, Shilin
Xu, Rui
Shu, Chang
Liu, Zhongchun
Zhou, Yuan
Reynolds, Gavin P.
Wang, Gaohua
Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
title Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
title_full Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
title_fullStr Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
title_full_unstemmed Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
title_short Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
title_sort nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494869/
https://www.ncbi.nlm.nih.gov/pubmed/36131290
http://dx.doi.org/10.1186/s12974-022-02591-y
work_keys_str_mv AT haokeke nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT wanghuiling nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT zhangyuejin nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT xiexinhui nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT huanghuan nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT chencheng nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT xushilin nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT xurui nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT shuchang nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT liuzhongchun nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT zhouyuan nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT reynoldsgavinp nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation
AT wanggaohua nicotinamidereversesdeficitsinpubertybornneuronsandcognitivefunctionaftermaternalseparation